{"id":"loperamide","rwe":[],"tags":[],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Disease of liver","Hemorrhagic diarrhea","Infectious diarrheal disease","Paralytic ileus"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"approved","trials":["NCT06892093","NCT01570634","NCT05677282","NCT06235931","NCT02686645","NCT06796296","NCT04238091","NCT06222255","NCT06896136","NCT03273855","NCT02400476","NCT04576208","NCT00591357","NCT01391962","NCT04186936","NCT02888899","NCT00727649","NCT02263365","NCT02354768","NCT06637683","NCT02711891","NCT02307591","NCT01780909","NCT04723056","NCT00401388","NCT05154396","NCT05252546","NCT02266849","NCT06179589","NCT01524783","NCT04366713","NCT02970591","NCT04172597","NCT01281982","NCT06519110","NCT02662855","NCT03705442","NCT04447443","NCT00954304","NCT00807326","NCT02099006","NCT02858310","NCT06936774","NCT01633203","NCT01297556","NCT02246816","NCT04736186","NCT00933465","NCT03548051","NCT00650637"],"aliases":["Imodium","Imodium AD"],"patents":[],"pricing":[{"market":"United States","source":"CMS National Average Drug Acquisition Cost (NADAC)","asOfDate":"2024-01-03","unitCost":"$0.0269/ML","priceType":"NADAC","sourceUrl":"https://data.medicaid.gov/dataset/4j6z-xnwq","annualCost":"$10","description":"LOPERAMIDE 1 MG/7.5 ML SOLN","retrievedDate":"2026-04-07"}],"allNames":"imodium","offLabel":[],"timeline":[],"brandName":"Imodium","companyId":"johnson-johnson","ecosystem":[],"mechanism":{"target":"Aldehyde oxidase, Cocaine esterase, D(4) dopamine receptor","novelty":"","modality":"Small molecule","drugClass":"Antidiarrheal (peripheral opioid agonist)","explanation":"Loperamide is an opioid receptor agonist that acts on the myenteric plexus of the gut wall, slowing intestinal motility and increasing water absorption. It does not cross the blood-brain barrier at therapeutic doses due to P-glycoprotein efflux, so it lacks central opioid effects (no euphoria, analgesia, or respiratory depression). Developed by Paul Janssen, it is one of the most widely used OTC medications for diarrhea.","oneSentence":"Peripheral mu-opioid receptor agonist that slows intestinal motility and increases fluid absorption without crossing the blood-brain barrier.","technicalDetail":""},"commercial":null,"references":[],"biosimilars":[],"companyName":"Johnson & Johnson (McNeil Consumer Healthcare)","competitors":[],"dataSources":[{"url":"https://data.medicaid.gov/dataset/4j6z-xnwq","name":"CMS National Average Drug Acquisition Cost (NADAC)","fields":["pricing"],"retrievedDate":"2026-04-07"},{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"},{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"loperamide","indications":{"approved":[{"name":"Diarrhea","diseaseId":"diarrhea","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Diarrhea Secondary to Inflammatory Bowel Disease","diseaseId":"diarrhea-secondary-to-inflammatory-bowel-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Traveler's diarrhea","diseaseId":"traveler's-diarrhea","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06892093","phase":"NA","title":"Efficacy and Safety of Probiotics Versus Standard Care in Preventing Diarrhea Induced by Neratinib in Breast Cancer Patients: A Prospective Randomized Controlled Clinical Trial","status":"RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","isPivotal":false,"enrollment":308,"indication":"HER2-positive Breast Cancer, Diarrhea Caused by Drug","completionDate":"2027-12"},{"nctId":"NCT01570634","phase":"Phase 2","title":"Proof-of-Concept, CASAD for Treatment of Clostridium Difficile Infection","status":"TERMINATED","sponsor":"Salient Pharmaceuticals Incorporated","isPivotal":false,"enrollment":2,"indication":"Diarrhoea, Clostridium Difficile","completionDate":"2012-09"},{"nctId":"NCT05677282","phase":"Phase 4","title":"A Randomized Controlled Trial Evaluating Single-dose Rifaximin Versus Azithromycin With Loperamide Adjunct for Treatment of Acute Watery Diarrhea","status":"RECRUITING","sponsor":"Henry M. Jackson Foundation for the Advancement of Military Medicine","isPivotal":false,"enrollment":150,"indication":"Diarrhoea;Acute, Diarrhea Travelers","completionDate":"2025-12"},{"nctId":"NCT06235931","phase":"NA","title":"Prospective, Single-arm, Single-center Clinical Study of Darcilil Combined With AI Combined With Pyrrotinib in the Treatment of Elderly Advanced Triple-positive Breast Cancer.","status":"RECRUITING","sponsor":"Second Affiliated Hospital of Soochow University","isPivotal":false,"enrollment":34,"indication":"Breast Neoplasms","completionDate":"2026-12-01"},{"nctId":"NCT02686645","phase":"Phase 2","title":"Fecal Microbiota Therapy for Recurrent Clostridium Difficile Infection","status":"UNKNOWN","sponsor":"Queen Elizabeth II Health Sciences Centre","isPivotal":true,"enrollment":50,"indication":"Clostridium Difficile Infection","completionDate":"2021-12"},{"nctId":"NCT06796296","phase":"NA","title":"The Safety and Efficacy of Transanal Irrigation in Patients from Low Anterior Resection Syndrome After Rectal Cancer Surgery : a Multicenter Prospective Randomized Controlled Trial (TraLARS Study)","status":"NOT_YET_RECRUITING","sponsor":"Seoul National University Hospital","isPivotal":false,"enrollment":94,"indication":"Low Anterior Resection Syndrome, Rectal Cancer Surgery","completionDate":"2029-12-31"},{"nctId":"NCT04238091","phase":"Phase 2","title":"Open Label Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia Areata","status":"WITHDRAWN","sponsor":"Lindsey Bordone","isPivotal":false,"enrollment":0,"indication":"Alopecia Areata, Alopecia Totalis","completionDate":"2022-03-02"},{"nctId":"NCT06222255","phase":"NA","title":"The Safety and Efficacy of Transanal Irrigation in Patients With Sleep Disturbance From Low Anterior Resection Syndrome After Rectal Cancer Surgery: A Multicenter Prospective Randomized Controlled Tri","status":"RECRUITING","sponsor":"Seoul National University Hospital","isPivotal":false,"enrollment":52,"indication":"Low Anterior Resection Syndrome, Rectal Cancer","completionDate":"2028-12-31"},{"nctId":"NCT06896136","phase":"Phase 1","title":"Phase 1, Randomized, Placebo-Controlled, Blinded Study in Healthy Adults Challenged With Enterotoxigenic Escherichia Coli, of the Safety, Tolerability and Anti-Diarrheal Activity of VENBETA6890, an Or","status":"COMPLETED","sponsor":"Mark Klempner","isPivotal":false,"enrollment":36,"indication":"Diarrhea Infectious","completionDate":"2025-05-22"},{"nctId":"NCT03273855","phase":"NA","title":"Randomized Controlled Trial of Fecal Microbiota Transplantation in Severe Obesity","status":"UNKNOWN","sponsor":"University Hospital of North Norway","isPivotal":false,"enrollment":60,"indication":"Obesity, Morbid","completionDate":"2023-05-01"},{"nctId":"NCT02400476","phase":"Phase 2","title":"An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide","status":"COMPLETED","sponsor":"Puma Biotechnology, Inc.","isPivotal":false,"enrollment":563,"indication":"Early Stage HER2+ Breast Cancer","completionDate":"2021-04-22"},{"nctId":"NCT04576208","phase":"Phase 2","title":"A Randomized Open-label Phase 2 Multicenter Study to Evaluate the Impact of Management Strategies on Gastrointestinal-Related Adverse Events in Patients With Non-Small Cell Lung Cancer Harboring EGFR ","status":"WITHDRAWN","sponsor":"Takeda","isPivotal":false,"enrollment":0,"indication":"Non-Small Cell Lung Cancer (NSCLC)","completionDate":"2022-07-31"},{"nctId":"NCT00591357","phase":"Phase 4","title":"Study of the Efficacy of Loperamide in Treating Patients for Clostridium Difficile Colitis and Diarrheal Disease of Unknown Cause Associated With Prior Antibiotic Therapy.","status":"SUSPENDED","sponsor":"Michael E. DeBakey VA Medical Center","isPivotal":false,"enrollment":120,"indication":"Antibiotic-Associated Diarrhea, Clostridium Difficile","completionDate":""},{"nctId":"NCT01391962","phase":"Phase 2","title":"A Phase II Trial In Which Patients With Metastatic Alveolar Soft Part Sarcoma Are Randomized to Either Sunitinib or Cediranib Monotherapy, With Cross-Over at Disease Progression","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","isPivotal":false,"enrollment":34,"indication":"Sarcoma, Alveolar Soft Part","completionDate":"2026-01-16"},{"nctId":"NCT04186936","phase":"Phase 1","title":"An Open-label, Randomized, Fasting, Two-period, Single-dose, Crossover Study to Assess Bioequivalence Between a Combination Caplet With Loperamide Hydrochloride and Simethicone (Janssen-Cilag, France)","status":"COMPLETED","sponsor":"McNeil AB","isPivotal":false,"enrollment":48,"indication":"Healthy","completionDate":"2019-12-26"},{"nctId":"NCT02888899","phase":"NA","title":"Percutaneous Tibial Nerve Stimulation in Combination With Biofeedback in Patients With Fecal Incontinence - A Randomized Controlled Trial","status":"UNKNOWN","sponsor":"University Hospital, Linkoeping","isPivotal":false,"enrollment":0,"indication":"Fecal Incontinence","completionDate":"2019-03"},{"nctId":"NCT00727649","phase":"Phase 2","title":"Efficacy and Mechanisms of Pharmacologic Treatment of Fecal Incontinence","status":"COMPLETED","sponsor":"US Department of Veterans Affairs","isPivotal":true,"enrollment":80,"indication":"Fecal Incontinence","completionDate":"2013-12"},{"nctId":"NCT02263365","phase":"Phase 3","title":"Prospective Randomized Control Study on Effect of Post Operative Loperamide in Decreasing Readmission for Dehydration in Colorectal Patients After Diverting Ileostomies","status":"TERMINATED","sponsor":"Cedars-Sinai Medical Center","isPivotal":true,"enrollment":40,"indication":"Dehydration, Diverting Ileostomy, Loperamide","completionDate":"2016-12-31"},{"nctId":"NCT02354768","phase":"Phase 3","title":"Evaluation of Lanreotide Efficacity in High Output Stoma: a Multicentric Randomized Study","status":"TERMINATED","sponsor":"University Hospital, Strasbourg, France","isPivotal":true,"enrollment":19,"indication":"High Output Stoma","completionDate":"2018-01-26"},{"nctId":"NCT06637683","phase":"NA","title":"Multi-Strain and High-Concentration Bacillus Probiotic Spores (LiveSpo COLON) in the Supportive Treatment of Inflammatory Bowel Disease (IBD): A Blind, Randomized, and Controlled Trial","status":"COMPLETED","sponsor":"Anabio R&D","isPivotal":false,"enrollment":60,"indication":"Inflammatory Bowel Diseases","completionDate":"2020-06-20"},{"nctId":"NCT02711891","phase":"EARLY/Phase 1","title":"Topical Loperamide Gel for Pain Reduction During Repeat Finger Lancing: A Randomized Double Blind Trial","status":"COMPLETED","sponsor":"Rush University Medical Center","isPivotal":false,"enrollment":34,"indication":"Pain","completionDate":"2015-12"},{"nctId":"NCT02307591","phase":"Phase 2","title":"Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola.","status":"WITHDRAWN","sponsor":"Emergency NGO Onlus","isPivotal":true,"enrollment":0,"indication":"Ebola Virus Disease","completionDate":"2015-07"},{"nctId":"NCT01780909","phase":"NA","title":"The Use of a Non-absorbable Marker for the Evaluation of the Gastrointestinal Transit. Evaluatie Van de Gastrointestinale Transit Aan de Hand Van de Niet-absorbeerbare Merker Paromomycine Sulfaat (Dut","status":"UNKNOWN","sponsor":"KU Leuven","isPivotal":false,"enrollment":10,"indication":"Concentration-Time Profiles in Stomach & Intestine.","completionDate":"2017-12"},{"nctId":"NCT04723056","phase":"NA","title":"Zemedy - Evaluation of Zemedy, a Cognitive Behavioral Therapy-based Digital Therapeutic Application for the Treatment of Irritable Bowel Syndrome","status":"TERMINATED","sponsor":"Stanford University","isPivotal":false,"enrollment":21,"indication":"IBS - Irritable Bowel Syndrome","completionDate":"2024-03-08"},{"nctId":"NCT00401388","phase":"Phase 2","title":"Sarcoma Alliance for Research Through Collaboration (SARC) Multicenter Trial: A Phase II Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas","status":"COMPLETED","sponsor":"AEterna Zentaris","isPivotal":false,"enrollment":72,"indication":"Chondrosarcomas, Alveolar Soft Part Sarcomas","completionDate":"2011-10"},{"nctId":"NCT05154396","phase":"Phase 2","title":"Neratinib Dose Escalation Regimen for HER2 Positive Early Breast Cancer","status":"UNKNOWN","sponsor":"Chinese Academy of Medical Sciences","isPivotal":false,"enrollment":60,"indication":"HER2-positive Breast Cancer","completionDate":"2024-12-31"},{"nctId":"NCT05252546","phase":"Phase 1","title":"A Single-centre, Open, Single-dose, Fixed-sequence Study to Investigate the Effect of Montmorillonite Power or Loperamide on the Pharmacokinetics of Pyrotinib in Healthy Chinese Adult Subjects","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","isPivotal":false,"enrollment":36,"indication":"HER2-positive Recurrent / Metastatic Breast Cancer","completionDate":"2022-08-02"},{"nctId":"NCT02266849","phase":"Phase 3","title":"Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study","status":"TERMINATED","sponsor":"Odense University Hospital","isPivotal":true,"enrollment":12,"indication":"Rectal Cancer, Ulcerative Colitis","completionDate":"2015-08"},{"nctId":"NCT06179589","phase":"NA","title":"Clinical Trial to Compare the Efficacy and Safety of a Multiple Amino-acid Based ORS \"VS002A\" With the Standard WHO-ORS in the Management of Noncholera Acute Watery Diarrhea in Infants and Young Child","status":"COMPLETED","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","isPivotal":false,"enrollment":312,"indication":"Acute Watery Diarrhoea","completionDate":"2023-04-30"},{"nctId":"NCT01524783","phase":"Phase 3","title":"A Randomized, Double-blind, Multicenter, Phase III Study of Everolimus (RAD001) Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced NET of GI ","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","isPivotal":true,"enrollment":302,"indication":"Advanced NET of GI Origin, Advanced NET of Lung Origin","completionDate":"2020-08-07"},{"nctId":"NCT04366713","phase":"Phase 2","title":"An Open-Label Phase 2 Study to Characterize Colon Pathology in Patients With HER2 Amplified Breast Cancer Treated With Neratinib","status":"COMPLETED","sponsor":"Puma Biotechnology, Inc.","isPivotal":false,"enrollment":6,"indication":"HER2 Amplified Breast Cancer","completionDate":"2021-12-28"},{"nctId":"NCT02970591","phase":"NA","title":"The Role of CARbohydrates in Irritable Bowel Syndrome (CARIBS): Protocol for a Randomized Controlled Trial Comparing Three Different Treatment Options","status":"COMPLETED","sponsor":"Sahlgrenska University Hospital","isPivotal":false,"enrollment":300,"indication":"Irritable Bowel Syndrome","completionDate":"2022-04-29"},{"nctId":"NCT04172597","phase":"Phase 2","title":"A Phase 2 Study of Poziotinib in Patients With EGFR or HER2 Activating Mutations in Advanced Malignancies","status":"TERMINATED","sponsor":"Spectrum Pharmaceuticals, Inc","isPivotal":false,"enrollment":1,"indication":"Breast Cancer, Colorectal Cancer","completionDate":"2022-03-29"},{"nctId":"NCT01281982","phase":"N/A","title":"(11C)N-Desmethyl-Loperamide as a Marker of P-Glycoprotein Function in Patients With Gliomas","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","isPivotal":false,"enrollment":2,"indication":"Low Grade Glioma, Glioblastoma Multiforme","completionDate":"2012-09-24"},{"nctId":"NCT06519110","phase":"Phase 2","title":"A Single-arm, Open-label, Multicenter Phase II Clinical Study of Neratinib Tablets Monotherapy in the Treatment of Advanced Solid Tumors With HER2 Mutations","status":"NOT_YET_RECRUITING","sponsor":"Convalife (Shanghai) Co., Ltd.","isPivotal":false,"enrollment":60,"indication":"Advanced Solid Tumor","completionDate":"2026-04-15"},{"nctId":"NCT02662855","phase":"Phase 2","title":"Efficacy of Favipiravir Against Severe Ebola Virus Disease","status":"COMPLETED","sponsor":"Beijing Institute of Pharmacology and Toxicology","isPivotal":false,"enrollment":77,"indication":"Ebola Virus Disease","completionDate":"2015-05"},{"nctId":"NCT03705442","phase":"Phase 2","title":"Probiotics as Adjuvant Therapy in the Treatment of Metastatic Colorectal Cancer: Randomized Double-blind Placebo-controlled Trial","status":"UNKNOWN","sponsor":"Marin Golčić","isPivotal":false,"enrollment":76,"indication":"Colorectal Cancer Metastatic","completionDate":"2020-02-09"},{"nctId":"NCT04447443","phase":"NA","title":"Impact of Dietary Fiber as Prebiotics on Chemotherapy-related Diarrhea in Patients With Gastrointestinal Tumors","status":"WITHDRAWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","isPivotal":false,"enrollment":0,"indication":"Chemotherapy-related Diarrhea","completionDate":"2021-06-30"},{"nctId":"NCT00954304","phase":"Phase 1","title":"Clinical Trial to Investigate the Duration of P-glycoprotein Inhibition After Oral Administration of HM30181AK Tablet in Healthy Male Subjects : An Open, Parallel Dose Group Design","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","isPivotal":false,"enrollment":30,"indication":"Healthy","completionDate":"2009-09"},{"nctId":"NCT00807326","phase":"Phase 4","title":"A Randomized, Parallel Group Comparison of Loperamide/Simeticone Caplet, Loperamide/Simeticone Chewable Tablet (IMODIUM® PLUS) and a Probiotic (Saccharomyces Boulardii) in the Treatment of Acute Diarr","status":"COMPLETED","sponsor":"McNeil AB","isPivotal":false,"enrollment":415,"indication":"Diarrhea","completionDate":"2009-11"},{"nctId":"NCT02099006","phase":"Phase 2","title":"Novel Topical Therapies for the Treatment of Genital Pain","status":"COMPLETED","sponsor":"University of Rochester","isPivotal":true,"enrollment":9,"indication":"Female Genital Diseases","completionDate":"2015-06"},{"nctId":"NCT02858310","phase":"Phase 1","title":"A Phase I/II Trial of T Cell Receptor Gene Therapy Targeting HPV-16 E7 for HPV-Associated Cancers","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","isPivotal":false,"enrollment":224,"indication":"Papillomavirus Infections, Cervical Intraepithelial Neoplasia","completionDate":"2025-07-02"},{"nctId":"NCT06936774","phase":"Phase 3","title":"Improving Functional Outcomes and Quality of Life in Patients With Rectal Cancer After Surgery With Intensified Follow-up & Surveillance - a Randomized Controlled Trial (iRECOVER)","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Basel, Switzerland","isPivotal":true,"enrollment":140,"indication":"LARS - Low Anterior Resection Syndrome, Rectal Cancer Surgery","completionDate":"2028-07-01"},{"nctId":"NCT01633203","phase":"N/A","title":"Prospective Observational Study of Patients With Locally Advanced Gastric Cancer Treated With Perioperative Chemotherapy and Surgery","status":"COMPLETED","sponsor":"Grupo Oncologico Cooperativo Chileno de Investigation","isPivotal":false,"enrollment":61,"indication":"Gastric Cancer","completionDate":"2018-12"},{"nctId":"NCT01297556","phase":"NA","title":"Examining Patient Attributes To Determine Optimal Treatment Outcome in Irritable Bowel Syndrome.","status":"UNKNOWN","sponsor":"Michigan Gastroenterology Institute","isPivotal":false,"enrollment":200,"indication":"Irritable Bowel Syndrome","completionDate":"2011-12"},{"nctId":"NCT02246816","phase":"Phase 3","title":"A Phase 3, Open Label Extension Study for Subjects That Complete Study MP-101-CL-001","status":"WITHDRAWN","sponsor":"Marathon Pharmaceuticals, LLC","isPivotal":true,"enrollment":0,"indication":"Short Bowel Syndrome, Short Gut Syndrome","completionDate":"2018-02"},{"nctId":"NCT04736186","phase":"Phase 2","title":"Prevention and Treatment of Pyrrolitinib-associated Diarrhea: a Prospective, Multicenter, Open-label Clinical Study","status":"UNKNOWN","sponsor":"Tianjin Medical University Cancer Institute and Hospital","isPivotal":true,"enrollment":470,"indication":"Breast Cancer","completionDate":"2023-04-30"},{"nctId":"NCT00933465","phase":"Phase 4","title":"Single Blinded Randomised Cross-over Study of Imodium Tablets Versus Imodium Syrup for the Treatment of Faecal Incontinence","status":"WITHDRAWN","sponsor":"University Hospital Southampton NHS Foundation Trust","isPivotal":false,"enrollment":0,"indication":"Fecal Incontinence","completionDate":"2010-05"},{"nctId":"NCT03548051","phase":"Phase 1","title":"Phase 1/2 Placebo Controlled, Partially-Blinded Clinical Trial to Assess the Safety and Efficacy of Microbial Restoration by Enema With Banked and Thawed Processed Stool in Individuals With One or Mor","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","isPivotal":false,"enrollment":10,"indication":"Clostridial Infection, Dysbiosis","completionDate":"2021-01-13"},{"nctId":"NCT00650637","phase":"Phase 3","title":"A Randomized, Open-Label, Third-Party Blinded Study for the Prophylaxis and Treatment of Nelfinavir-associated Diarrhea","status":"TERMINATED","sponsor":"Pfizer","isPivotal":true,"enrollment":17,"indication":"Diarrhea","completionDate":"2003-08"}],"whoEssential":true,"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"Oral","frequency":"As needed (max 16mg/day)","formulation":"Capsule, Tablet, Liquid"},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"therapeuticAreas":["Metabolic"],"biosimilarFilings":[],"firstApprovalDate":"1976-12-28","companionDiagnostics":[],"firstApprovalCountry":"United States","genericManufacturerList":[],"modality":"Small molecule","aiSummary":"Loperamide (Imodium) is the world\\","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":7,"withResults":3},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}